Publication | Open Access

Synthesis and structure-activity relationship of 4-(1,3-benzothiazol-2-yl)-thiophene-2-sulfonamides as cyclin-dependent kinase 5 (cdk5)/p25 inhibitors

Medicinal ChemistryHeterocyclicMedicineNatural SciencesRational Drug DesignStructure-activity RelationshipOrganic ChemistryPharmacotherapyAnti-cancer AgentChemistryCyclin-dependent Kinase 5Heterocycle ChemistryPharmacologyPharmaceutical ChemistryDrug Discovery/P25 Inhibitors